Railroading at the FDA
Nat Biotechnol
.
2016 Nov 8;34(11):1078.
doi: 10.1038/nbt.3733.
PMID:
27824847
DOI:
10.1038/nbt.3733
No abstract available
Publication types
Editorial
MeSH terms
Clinical Trials as Topic
Decision Making
Drug Approval
Humans
Morpholinos / therapeutic use
Muscular Dystrophy, Duchenne / drug therapy
United States
United States Food and Drug Administration*
Substances
Morpholinos
eteplirsen